A 68-year-old man presents to the clinic reporting progressive yellowing of his skin and eyes over the past three weeks. He has noticed dark urine, pale-colored stools, and an unintentional 5-kg (11-lb) weight loss during this time. He denies any abdominal pain, fever, or chills. Physical examination is notable for scleral icterus and a palpable, non-tender mass in the right upper quadrant. Arrange the following imaging and image-guided modalities in the most appropriate standard sequence for diagnosing and staging this patient's suspected condition, starting with the initial step.
- 1Transabdominal ultrasonography of the right upper quadrant
- 2Pancreatic protocol multiphasic computed tomography (CT) of the abdomen
- 3Endoscopic ultrasonography (EUS) with fine-needle aspiration
Cevap
The correct sequence is: Transabdominal ultrasonography, followed by Pancreatic protocol multiphasic CT, and finally Endoscopic ultrasonography (EUS) with fine-needle aspiration.
The patient's presentation of painless jaundice and a palpable gallbladder (Courvoisier sign) suggests a malignant obstruction of the distal common bile duct, typically due to pancreatic head cancer. The evidence-based diagnostic algorithm mandates starting with the least invasive test. Transabdominal ultrasound confirms intra- and extra-hepatic biliary dilation and excludes simple choledocholithiasis. Once a malignant stricture is suspected based on ultrasound findings, a pancreatic protocol multiphasic CT scan is the next best step. It provides high-resolution cross-sectional imaging to identify the primary tumor, assess locoregional extent (specifically involvement of the superior mesenteric artery and vein or celiac axis), and detect hepatic metastases. Finally, once the patient is deemed a potential candidate for treatment based on CT staging, Endoscopic Ultrasonography (EUS) with fine-needle aspiration is performed to obtain the necessary tissue for histological confirmation.
Adım Adım Çözüm
Anahtar Kavram
Diagnostic sequencing for suspected pancreatic malignancy (painless jaundice).